272 related articles for article (PubMed ID: 10037106)
1. Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer.
Rudolph P; Alm P; Heidebrecht HJ; Bolte H; Ratjen V; Baldetorp B; Fernö M; Olsson H; Parwaresch R
J Natl Cancer Inst; 1999 Feb; 91(3):271-8. PubMed ID: 10037106
[TBL] [Abstract][Full Text] [Related]
2. Prognostic values of proliferative markers ki-67 and repp86 in breast cancer.
Mohsenifar J; Almassi-Aghdam M; Mohammad-Taheri Z; Zare K; Jafari B; Atri M; Mortazavi SH; Azadeh P; Bagherzadeh M; Azargashb E; Rahimi F
Arch Iran Med; 2007 Jan; 10(1):27-31. PubMed ID: 17198450
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: its prognostic value on short-term recurrences.
Gaglia P; Bernardi A; Venesio T; Caldarola B; Lauro D; Cappa AP; Calderini P; Liscia DS
Eur J Cancer; 1993; 29A(11):1509-13. PubMed ID: 8217353
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumor cell proliferation analyzed in fine needle aspirates from primary breast cancer.
Billgren AM; Tani E; Liedberg A; Skoog L; Rutqvist LE
Breast Cancer Res Treat; 2002 Jan; 71(2):161-70. PubMed ID: 11881912
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 5 Ki-67 antibodies regarding reproducibility and capacity to predict prognosis in breast cancer: does the antibody matter?
Ács B; Kulka J; Kovács KA; Teleki I; Tőkés AM; Meczker Á; Győrffy B; Madaras L; Krenács T; Szász AM
Hum Pathol; 2017 Jul; 65():31-40. PubMed ID: 28188752
[TBL] [Abstract][Full Text] [Related]
6. Concurrent overexpression of p53 and c-erbB-2 correlates with accelerated cycling and concomitant poor prognosis in node-negative breast cancer.
Rudolph P; Alm P; Olsson H; Heidebrecht HJ; Fernö M; Baldetorp B; Parwaresch R
Hum Pathol; 2001 Mar; 32(3):311-9. PubMed ID: 11274641
[TBL] [Abstract][Full Text] [Related]
7. Breast cancer cell kinetics: immunocytochemical determination of growth fractions by monoclonal antibody Ki-67 and correlation with flow cytometric S-phase and with some features of tumor aggressiveness.
Gasparini G; Pozza F; Meli S; Reitano M; Santini G; Bevilacqua P
Anticancer Res; 1991; 11(6):2015-21. PubMed ID: 1776834
[TBL] [Abstract][Full Text] [Related]
8. MIB-1 labelling index is an independent prognostic marker in primary breast cancer.
Jansen RL; Hupperets PS; Arends JW; Joosten-Achjanie SR; Volovics A; Schouten HC; Hillen HF
Br J Cancer; 1998 Aug; 78(4):460-5. PubMed ID: 9716027
[TBL] [Abstract][Full Text] [Related]
9. Prognostic comparative study of S-phase fraction and Ki-67 index in breast carcinoma.
Pinto AE; André S; Pereira T; Nóbrega S; Soares J
J Clin Pathol; 2001 Jul; 54(7):543-9. PubMed ID: 11429427
[TBL] [Abstract][Full Text] [Related]
10. Lack of prognostic significance of the monoclonal antibody Ki-S1, a novel marker of proliferative activity, in node-negative breast carcinoma.
Bevilacqua P; Verderio P; Barbareschi M; Bonoldi E; Boracchi P; Dalla Palma P; Gasparini G
Breast Cancer Res Treat; 1996; 37(2):123-33. PubMed ID: 8750580
[TBL] [Abstract][Full Text] [Related]
11. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
Keshgegian AA; Cnaan A
Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
[TBL] [Abstract][Full Text] [Related]
12. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
13. Tumor-infiltrating lymphocytes, tumor characteristics, and recurrence in patients with early breast cancer.
Kim ST; Jeong H; Woo OH; Seo JH; Kim A; Lee ES; Shin SW; Kim YH; Kim JS; Park KH
Am J Clin Oncol; 2013 Jun; 36(3):224-31. PubMed ID: 22495453
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ki-67 and topoisomerase IIalpha expression in infiltrating ductal carcinoma of the breast. A multivariate analysis of 863 cases.
Rudolph P; MacGrogan G; Bonichon F; Frahm SO; de Mascarel I; Trojani M; Durand M; Avril A; Coindre JM; Parwaresch R
Breast Cancer Res Treat; 1999 May; 55(1):61-71. PubMed ID: 10472780
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic significance of the S-phase and MIB1 (Ki-67) proliferation parameters in node-negative breast carcinoma].
Harbeck N; Dettmar P; Thomssen Ch; Pache L; Ziffer P; Fizi K; Jänicke F; Nathrath W; Schmitt M; Graeff H
Gynakol Geburtshilfliche Rundsch; 1995; 35 Suppl 1():142-7. PubMed ID: 8672914
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of Ki-67 compared to S-phase fraction in axillary node-negative breast cancer.
Brown RW; Allred CD; Clark GM; Osborne CK; Hilsenbeck SG
Clin Cancer Res; 1996 Mar; 2(3):585-92. PubMed ID: 9816207
[TBL] [Abstract][Full Text] [Related]
17. Proliferating cell nuclear antigen immunohistochemistry using monoclonal antibody 19A2 and a new antigen retrieval technique has prognostic impact in archival paraffin-embedded node-negative breast cancer.
Siitonen SM; Kallioniemi OP; Isola JJ
Am J Pathol; 1993 Apr; 142(4):1081-9. PubMed ID: 7682759
[TBL] [Abstract][Full Text] [Related]
18. Proliferating-cell nuclear antigen (PC10) immunolabelling and other proliferation indices as prognostic factors in breast cancer.
Aaltomaa S; Lipponen P; Papinaho S; Syrjänen K
J Cancer Res Clin Oncol; 1993; 119(5):288-94. PubMed ID: 8095051
[TBL] [Abstract][Full Text] [Related]
19. The utility of mitotic index, oestrogen receptor and Ki-67 measurements in the creation of novel prognostic indices for node-negative breast cancer.
Clahsen PC; van de Velde CJ; Duval C; Pallud C; Mandard AM; Delobelle-Deroide A; van den Broek L; van de Vijver MJ
Eur J Surg Oncol; 1999 Aug; 25(4):356-63. PubMed ID: 10419704
[TBL] [Abstract][Full Text] [Related]
20. Mucin antigens expression and Ki-67 labeling in breast cancer: the peculiarity in scirrhous carcinoma.
Nomoto M; Yonezawa S; Tokunaga M; Kim YS; Sato E
Pathol Int; 1995 Mar; 45(3):233-9. PubMed ID: 7787994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
